Evaluate the Efficacy and Safety of LO2A Eye Drops for Symptomatic Improvement of Dry Eye in Patients With Sjögren's Syndrome
Phase 4
Completed
- Conditions
- Dry Eye Due to Sjögren's Syndrome
- Interventions
- Drug: LO2A eye drops
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 60
- Registration Number
- NCT03319420
- Locations
- 🇮🇱
Rabin MC, Petah tikva, Israel
🇮🇱Rambam, Haifa, Israel
🇮🇱HaEmek MC, Afula, Israel
To Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Conjunctivochalasis
Phase 2
Completed
- Conditions
- Conjunctivochalasis
- Interventions
- Drug: LO2ADrug: Placebo
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2017-10-27
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 13
- Registration Number
- NCT02810119
- Locations
- 🇮🇱
Barzilai MC, Ashkelon, Israel
Evaluate the Efficacy and Safety of LO2A Eye Drops in Patients With Moderate to Severe Conjunctivochalasis
Phase 2
Completed
- Conditions
- Conjunctivochalasis
- Interventions
- Drug: LO2ADrug: Saline
- First Posted Date
- 2016-06-17
- Last Posted Date
- 2021-02-25
- Lead Sponsor
- Ocuwize LTD
- Target Recruit Count
- 62
- Registration Number
- NCT02804191
- Locations
- 🇮🇱
Hadassah, Jerusalem, Israel
🇮🇱Rambam, Haifa, Israel
🇮🇱Ichilov Tel Aviv hospital, Tel Aviv, Israel
© Copyright 2025. All Rights Reserved by MedPath